CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies
Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the ...
Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the ...
Robert F. Kennedy Jr. forcing Peter Marks out of the Food and Drug Administration has blown a hole in the ...
MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to ...
Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is ...
Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Robert F. Kennedy Jr.’s disclosure on Wednesday that he invested in a gene-editing biotech belies a years-long track record of ...
Prospective health secretary Robert F. Kennedy Jr. invested in biotechnology and had multiple sources of income in 2022 and 2023, ...
Newcells Biotech (“Newcells”), a leading drug discovery partner specializing in the development of in vitro models and bespoke assay services to improve ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.